Niquitin Mini (Nicotine)

Nicotine, the active ingredient in Niquitin Mini, is a nicotinic receptor agonist presented as an oromucosal product for use on the oral mucosa. It is employed to aid smoking cessation in adult individuals who are trying to quit tobacco and to lessen nicotine withdrawal symptoms.

GNH USA supplies Niquitin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, hospitals and clinics worldwide, with established distribution channels across the EU, Middle East and Asia and adhering to stringent quality standards.

Nicotine, a nicotinic receptor agonist, is used in smoking cessation to mitigate nicotine withdrawal and support quitting efforts. - Smoking cessation: helps reduce cravings and withdrawal symptoms in adults attempting to quit tobacco. - Tobacco dependence: provides a controlled nicotine source to facilitate gradual reduction of nicotine intake. - Relapse prevention: assists former smokers in maintaining abstinence by alleviating occasional urges.

Nicotine administered via Niquitin Mini may cause a range of oral and systemic reactions.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: transient feeling of queasiness. - Headache: mild to moderate headache. - Dizziness: brief episodes of light‑headedness. - Increased salivation: temporary excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiovascular events: palpitations or chest pain. - Severe nausea/vomiting: persistent and intense gastrointestinal upset. - Hypotension: unusually low blood pressure. - Throat ulceration: persistent sore throat or ulcer formation.

When using Niquitin Mini, consider the following precautions to ensure safe and effective use. - Age restriction: not recommended for individuals under 18 years of age. - Cardiovascular disease: use with caution in patients with heart conditions. - Diabetes: monitor blood glucose as nicotine may affect glycemic control. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Concomitant nicotine products: avoid using other nicotine replacement therapies simultaneously to prevent excess dosing. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Nicotine can interact with other medicines; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Beta‑blockers: nicotine can reduce their effectiveness in controlling heart rate.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance side‑effects such as insomnia or agitation. - Antihypertensive agents: nicotine may counteract blood pressure‑lowering effects. - Caffeine: nicotine can increase stimulant effects, leading to jitteriness.